|
|
|
|
| LEADER |
00000cam a22000004a 4500 |
| 001 |
in00002004243 |
| 005 |
20151031125649.0 |
| 008 |
040105s2004 nyu b 001 0 eng |
| 010 |
|
|
|a 2004041212
|
| 020 |
|
|
|a 0375508465 (cloth : alk. paper)
|
| 035 |
|
|
|a (OCoLC)ocm54035188
|
| 040 |
|
|
|a DLC
|c DLC
|d KUT
|d DNJ
|d UtOrBLW
|
| 042 |
|
|
|a pcc
|
| 043 |
|
|
|a n-us---
|
| 049 |
|
|
|a TXAM
|
| 050 |
0 |
0 |
|a HD9666.5
|b .A74 2004
|
| 082 |
0 |
0 |
|a 338.4/36151/0973
|2 22
|
| 096 |
|
|
|a QV 736
|b A583t 2004
|
| 100 |
1 |
|
|a Angell, Marcia.
|
| 245 |
1 |
4 |
|a The truth about the drug companies :
|b how they deceive us and what to do about it /
|c Marcia Angell.
|
| 250 |
|
|
|a 1st ed.
|
| 264 |
|
1 |
|a New York :
|b Random House,
|c [2004]
|
| 264 |
|
4 |
|c ©2004
|
| 300 |
|
|
|a xx, 305 pages ;
|c 25 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Introduction : drugs are different -- The $200 billion colossus -- The creation of a new drug -- How much does the pharmaceutical industry really spend on R & D? -- Just how innovative is this industry? -- "Me-too" drugs : the main business of the pharmaceutical industry -- How good are new drugs? -- The hard sell : lures, bribes, and kickbacks -- Marketing masquerading as education -- Marketing masquerading as research -- Patent games : stretching out monopolies -- Buying influence : how the industry makes sure it gets its way -- Is the party over? -- How to save the pharmaceutical industry, and get our money's worth.
|
| 650 |
|
0 |
|a Pharmaceutical industry
|z United States
|x Costs.
|
| 650 |
|
0 |
|a Drugs
|x Prices
|z United States.
|
| 650 |
|
0 |
|a Drugs
|x Research
|z United States
|x Finance.
|
| 650 |
|
0 |
|a Prescription pricing
|z United States.
|
| 650 |
|
0 |
|a Advertising
|x Drugs
|z United States.
|
| 650 |
|
0 |
|a Pharmaceutical policy
|z United States.
|
| 650 |
|
2 |
|a Pharmaceutical Preparations
|z United States.
|
| 650 |
|
2 |
|a Drug Industry
|x economics
|z United States.
|
| 650 |
|
2 |
|a Pharmaceutical Preparations
|x economics
|z United States.
|
| 650 |
|
2 |
|a Research
|z United States.
|
| 650 |
|
2 |
|a Prescription Fees
|z United States.
|
| 650 |
|
2 |
|a Drug Costs
|z United States.
|
| 650 |
|
2 |
|a Marketing
|z United States.
|
| 650 |
|
2 |
|a Advertising as Topic
|z United States.
|
| 948 |
|
|
|a cataloged
|b h
|c 2005/2/15
|d c
|e ceaton
|f 12:39:54 pm
|
| 994 |
|
|
|a C0
|b TXA
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 7d1f993e-0d37-35cc-be80-fd0b780a2d35
|i 66c789b3-ac98-307d-925b-2977d3bf5b8e
|t 0
|
| 952 |
f |
f |
|p normal
|a Texas A&M University
|b College Station
|c Sterling C. Evans Library
|d Evans: Library Stacks
|t 0
|e HD9666.5 .A74 2004
|h Library of Congress classification
|i unmediated -- volume
|m A14831763905
|
| 998 |
f |
f |
|a HD9666.5 .A74 2004
|t 0
|l Evans: Library Stacks
|